To characterize the tumor killing activity mediated by anti-CAIX mAbs, a luciferase-expressing CAIX+ RCC cell line was transplanted orthotopically to facilitate measurement of tumor growth. This evidence concerns the gene CA9 and renal cell carcinoma.